Skip to content

Altimmune ALT Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Eli Lilly logo
Eli LillyLLY
Merck & Co. logo
Merck & Co.MRK
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
Wave Life Sciences logo
Wave Life SciencesWVE
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's software and technology licenses, net?
Altimmune (ALT) reported software and technology licenses, net of $746K in Q1 2026.
How has Altimmune's software and technology licenses, net changed year-over-year?
Altimmune's software and technology licenses, net decreased by 53.9% year-over-year, from $1.62M to $746K.
What is the long-term trend for Altimmune's software and technology licenses, net?
Over 5 years (2020 to 2025), Altimmune's software and technology licenses, net has grown at a 7.8% compound annual growth rate (CAGR), from $977.24K to $1.43M.